Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001507-19Phase 4Completed
Phase 4, single-arm trial of somatropin in growth disorder and Small for gestational age (SGA), sponsored by National Children's Hospital. Primary endpoint: Height gain (3-year ΔSDS). Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001507-19.